Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
153 hedge funds and large institutions have $396M invested in Sciclone Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 23 closing their positions.
544% more call options, than puts
Call options by funds: $290K | Put options by funds: $45K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
12% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 49
1% more funds holding
Funds holding: 151 → 153 (+2)
0% less capital invested
Capital invested by funds: $396M → $396M (-$505K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$12.5M |
| 2 |
JP Morgan Chase
New York
|
+$4.66M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.99M |
| 4 |
Renaissance Technologies
New York
|
+$3.85M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$16.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$14.2M |
| 3 |
SI
Sensato Investors
San Francisco,
California
|
-$3.99M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.04M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3M |
SCLN Hedge Fund Activity: Q4 2016 in Review
153 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q4 2016, worth a combined $396M — down 0.13% from $396M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new SCLN positions and 23 closed out — a net gain of 6 holders — while 55 added to existing stakes and 49 trimmed.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $12.5M. The largest seller was Numeric Investors, cutting an estimated $16.2M.
- 153 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q4 2016, up from 151 in Q3 2016.
- Funds reported $396M of Sciclone Pharmaceuticals Inc stock for Q4 2016, down 0.13% quarter-over-quarter.
- 29 funds opened new Sciclone Pharmaceuticals Inc positions in Q4 2016 and 23 closed out, a net change of +6 holders.
- The largest Sciclone Pharmaceuticals Inc buyer in Q4 2016 was Stonepine Capital Management, an estimated $12.5M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q4 2016 was Numeric Investors, an estimated $16.2M sold.
Based on aggregated 13F filings for Q4 2016.